Bill Title: Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Spectrum: Committee Bill

Status: (Failed) 2024-04-30 - Senate Died in Committee [SB236 Detail]

Text: Latest bill text (Introduced) [PDF]

---

Sponsors

Name	Type	Sponsorship	District	Financial	Encyclopedia	Biography
Senate Public Health and Welfare Committee	Primary	Sponsored Bills	N/A	N/A	N/A	N/A

Social Comments on KS SB236